Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-Cov-2 Infection (COVID-BioVac)

NCT05276388 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT05276388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05276388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-Cov-2 Infection (COVID-BioVac)
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2021
Completion date
March 31, 2026
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections